|
Antiepileptic drugs
Citations 131-140 of 224 total displayed.
|
Past content
(since Jan 2001):
|
- CLINICAL/SCIENTIFIC NOTES
Recreational use of phenytoin, marijuana, and alcohol: A case report
- Kristen Jessen
Neurology 2004; 62: 2330.
[Full text]
[PDF]
- EDITORIALS
Marijuana as a treatment for epilepsy and multiple sclerosis?: A "grass roots" movement
- Joseph I. Sirven and Anne T. Berg
Neurology 2004; 62: 1924-1925.
[Full text]
[PDF]
- ARTICLES
Antiepileptic drug use increases rates of bone loss in older women: A prospective study
- K. E. Ensrud, T. S. Walczak, T. Blackwell, E. R. Ensrud, P. J. Bowman, and K. L. Stone
Neurology 2004; 62: 2051-2057.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Marijuana use and epilepsy: Prevalence in patients of a tertiary care epilepsy center
- D. W. Gross, J. Hamm, N. L. Ashworth, and D. Quigley
Neurology 2004; 62: 2095-2097.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
Levetiracetam in the treatment of idiopathic hemifacial spasm
- Dirk Deleu
Neurology 2004; 62: 2134-2135.
[Full text]
[PDF]
- SPECIAL ARTICLES
Practice Parameter: Medical Treatment of Infantile Spasms: Report of the American Academy of Neurology and the Child Neurology Society
- M. T. Mackay, S. K. Weiss, T. Adams-Webber, S. Ashwal, D. Stephens, K. Ballaban-Gill, T. Z. Baram, M. Duchowny, D. Hirtz, J. M. Pellock, W. D. Shields, S. Shinnar, E. Wyllie, and O. C. Snead, III
Neurology 2004; 62: 1668-1681.
[Abstract]
[Full text]
[PDF]
- SPECIAL ARTICLES
Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society
- J. A. French, A. M. Kanner, J. Bautista, B. Abou-Khalil, T. Browne, C. L. Harden, W. H. Theodore, C. Bazil, J. Stern, S. C. Schachter, D. Bergen, D. Hirtz, G. D. Montouris, M. Nespeca, B. Gidal, W. J. Marks, Jr., W. R. Turk, J. H. Fischer, B. Bourgeois, A. Wilner, R. E. Faught, Jr., R. C. Sachdeo, A. Beydoun, and T. A. Glauser
Neurology 2004; 62: 1252-1260.
[Abstract]
[Full text]
[PDF]
- SPECIAL ARTICLES
Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society
- J. A. French, A. M. Kanner, J. Bautista, B. Abou-Khalil, T. Browne, C. L. Harden, W. H. Theodore, C. Bazil, J. Stern, S. C. Schachter, D. Bergen, D. Hirtz, G. D. Montouris, M. Nespeca, B. Gidal, W. J. Marks, Jr., W. R. Turk, J. H. Fischer, B. Bourgeois, A. Wilner, R. E. Faught, Jr., R. C. Sachdeo, A. Beydoun, and T. A. Glauser
Neurology 2004; 62: 1261-1273.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Reversible parkinsonism with normal ß-CIT-SPECT in patients exposed to sodium valproate
- K. Easterford, P. Clough, M. Kellett, K. Fallon, and S. Duncan
Neurology 2004; 62: 1435-1437.
[Abstract]
[Full text]
[PDF]
- VIEWS & REVIEWS
Cognitive side effects of antiepileptic drugs in children
- David W. Loring and Kimford J. Meador
Neurology 2004; 62: 872-877.
[Abstract]
[Full text]
[PDF]
|
|
